Product Information

PERAMPANEL 12 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $14.0256 per EA under NDC 00480706856. Its NADAC has been published 52 times since Nov 19, 2025.

FDA first approved this application on May 23, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PERAMPANEL 12 MG TABLET

Perampanel
$14.0256per EA
DEA Schedule CIII

Strength

12 mg/1

NDC

00480706856

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PERAMPANEL

Approval Type

Generic (ANDA)

FDA Application

ANDA209801

FDA Approved

5/23/2025

TE Code

AB

On Market Since

5/29/2025

Pharmacological Classes

AMPA Receptor Antagonists
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 3A4 Inhibitors
Noncompetitive AMPA Glutamate Receptor Antagonist
UGT1A9 Inhibitors
UGT2B7 Inhibitors

Price Statistics

The NADAC for PERAMPANEL 12 MG TABLET has been published 52 times since Nov 19, 2025, and over the history we have for it it has declined 55.4%. The table below summarizes its recorded NADAC range and movement.

Current price$14.0256 per EA
All-time high$31.9208 (Mar 11, 2026)
All-time low$14.0256 (Oct 21, 2026)
52-week high$31.9208
52-week low$14.0256
Median price$25.7575
Average price$24.2663
Largest weekly change-15.0% (Jun 17, 2026)
Weeks tracked52
Tracking sinceNov 19, 2025

Price History

1W

0.0%

1M

-2.6%

3M

-18.9%

6M

-49.5%

1Y

N/A

3Y

N/A

5Y

N/A

All

-55.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PERAMPANEL 12 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PERAMPANEL 12 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $14.0256 per EA (NDC 00480706856), effective Nov 11, 2026.

How has the price of PERAMPANEL 12 MG TABLET changed over time?

Over the history we have for it, the NADAC for PERAMPANEL 12 MG TABLET has declined 55.4%. It has been tracked across 52 weekly CMS publications since Nov 19, 2025.

What are the highest and lowest recorded NADAC prices for PERAMPANEL 12 MG TABLET?

Since Nov 19, 2025, the NADAC for PERAMPANEL 12 MG TABLET has ranged from a low of $14.0256 (Oct 21, 2026) to a high of $31.9208 (Mar 11, 2026), with a median of $25.7575 per EA.

Are there cheaper alternatives to PERAMPANEL 12 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PERAMPANEL 12 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PERAMPANEL 12 MG TABLET?

PERAMPANEL 12 MG TABLET (NDC 00480706856) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.